AFFF cancer lawsuit

AFFF Manufacturers Manipulated Studies That Proved The Health Risks Of AFFF

Lawsuits allege firefighters were deceived deliberatively by the manufacturers of firefighting foam

Tuesday, July 25, 2023 - 3M, DuPont, and dozens of other companies involved in manufacturing and selling AFF foam stand accused of deliberately manipulating scientific studies to suppress unfavorable research and distort public discourse regarding the cancer-causing product. One study published by the Annals of Global Health in an article titled: " The Devil they Knew: Chemical Documents Analysis of Industry Influence on PFAS Science," tells readers that AFFF manufacturers knew as early as 1970 that firefighting foam was toxic if inhaled or otherwise ingested and failed to warn firefighters. "Our review of industry documents shows that companies knew PFAS was "highly toxic when inhaled and moderately toxic when ingested" by 1970, forty years before the public health community. Further, the industry used several strategies that have been shown common to tobacco, pharmaceutical, and other industries to influence science and regulation -- most notably, suppressing unfavorable research and distorting public discourse," the AGH reports. In another study, researchers found that firefighters in Scotland are 60% more likely to die from prostate cancer than the general public. Corporate malfeasance to the degree committed by the manufacturers of firefighting foam has led to enormous punitive damages being awarded to plaintiffs with cancer.

AFFF cancer lawsuits are being filed by firefighters throughout the United States who have developed any one of a wide variety of types of cancer allegedly from using AFFF to extinguish jet fuel and petroleum fires. The product is also widely used as a degreaser to clean military weaponry and equipment and to clean grease spills on industrial garage floors. Types of cancer presumed to have been caused by working with firefighting foam include kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, prostate cancer, pancreatic cancer, bladder cancer, and liver cancer according to some. One firefighter recently filed a lawsuit against 3M, DuPont, and other AFFF manufacturers blaming his prostate cancer on using firefighting foam throughout his career. According to AboutLawsuits.com, " John Wilkes, a former firefighter from California, filed a complaint (PDF) in the U.S. District Court for the District of South Carolina on July 13, indicating that 3M Company, Chemours, Du Pont, and numerous other chemical and safety equipment manufacturers should be held responsible for his prostate cancer diagnosis."

Prostate cancer, a significant health concern for men, can be detected early through vigilant monitoring of specific warning signs. Among the key indicators are changes in urinary habits, such as frequent urination, weak or interrupted flow, or difficulty starting and stopping. Additionally, experiencing pain or discomfort during urination or ejaculation, blood in the urine or semen, and persistent lower back or pelvic pain should prompt medical attention. Regular screening for men over 50, or those with a family history, is essential to catch potential issues early. Promptly reporting these symptoms to a healthcare professional increases the chances of timely diagnosis and effective treatment. In addition, firefighters who have come into contact with AFFF in the general course of their career should watch for early signs they may have the deadly disease. ">

Information provided by AFFFLawsuitCenter.com, a website devoted to providing news about AFFF and PFAS cancer, lymphoma and leukaemia claims, including a free no-cost, no-obligation AFFF Lawsuit Claim.

More Recent AFFF Lawsuit News:

View all AFFF Lawsuit News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer, Lymphoma or Leukaemia After Exposure to Firefighting Foam

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.